Towards a science-based testing strategy to identify maternal thyroid hormone imbalance and neurodevelopmental effects in the progeny - Part IV: the ECETOC and CLE Proposal for a Thyroid Function-Related Neurodevelopmental Toxicity Testing and Assessment Scheme (Thyroid-NDT-TAS)

• Published in: Critical reviews in toxicology 2023-08, Vol.53 (6), p.1-371
• Main Authors: Melching-Kollmuss, Stephanie, Bothe, Kathrin, Charlton, Alex, Gangadharan, Babunilayam, Ghaffari, Rashin, Jacobi, Sylvia, Marty, Sue, Marxfeld, Heike-Antje, McInnes, Elizabeth F, Sauer, Ursula G, Sheets, Larry P, Strupp, Christian, Tinwell, Helen, Wiemann, Christiane, Botham, Philip A, van Ravenzwaay, Bennard
• Format: Article
• Language: English
• ISSN: 1040-8444; 1547-6898
• DOI: 10.1080/10408444.2023.2231033

Following the European Commission Endocrine Disruptor Criteria, substances shall be considered as having endocrine disrupting properties if they (a) elicit adverse effects, (b) have endocrine activity, and (c) the two are linked by an endocrine mode-of-action (MoA) unless the MoA is not relevant for humans. A comprehensive, structured approach to assess whether substances meet the Endocrine Disruptor Criteria for the thyroid modality (EDC-T) is currently unavailable. Here, the European Centre for Ecotoxicology and Toxicology of Chemicals Thyroxine Task Force and CropLife Europe propose a Function-Related euro evelopmental oxicity esting and ssessment cheme (Thyroid-NDT-TAS). In Tier 0, before entering the Thyroid-NDT-TAS, all available , and data are submitted to weight-of-evidence (WoE) evaluations to determine whether the substance of interest poses a concern for thyroid disruption. If so, Tier 1 of the Thyroid-NDT-TAS includes an initial MoA and human relevance assessment (structured by the key events of possibly relevant adverse outcome pathways) and the generation of supportive / data, if relevant. Only if Tier 1 is inconclusive, Tier 2 involves higher-tier testing to generate further thyroid- and/or neurodevelopment-related data. Tier 3 includes the final MoA and human relevance assessment and an overarching WoE evaluation to draw a conclusion on whether, or not, the substance meets the EDC-T. The Thyroid-NDT-TAS is based on the state-of-the-science, and it has been developed to minimise animal testing. To make human safety assessments more accurate, it is recommended to apply the Thyroid-NDT-TAS during future regulatory assessments.